SCM
Soleus Capital Management Portfolio holdings
AUM
$1.45B
This Quarter Return
-4.26%
1 Year Return
+18.23%
3 Year Return
+274.85%
5 Year Return
+440.77%
10 Year Return
–
AUM
$642M
AUM Growth
+$642M
(-1.3%)
Cap. Flow
+$70.9M
Cap. Flow
% of AUM
11.04%
Top 10 Holdings %
Top 10 Hldgs %
47.56%
Holding
90
New
25
Increased
18
Reduced
19
Closed
18
Top Buys
| 1 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$28.8M |
| 2 |
United Therapeutics
UTHR
|
$18.8M |
| 3 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
$12.7M |
| 4 |
Enanta Pharmaceuticals
ENTA
|
$10.4M |
| 5 |
Organogenesis Holdings
ORGO
|
$9.11M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$27.9M |
| 2 |
The Beauty Health Co
SKIN
|
$19M |
| 3 |
ITMR
Itamar Medical Ltd. American Depository Shares
ITMR
|
$10.6M |
| 4 |
NovoCure
NVCR
|
$8.33M |
| 5 |
BioAtla
BCAB
|
$8.21M |
Sector Composition
| 1 | Healthcare | 91.89% |
| 2 | Financials | 1.01% |
| 3 | Consumer Staples | 0.82% |
| 4 | Real Estate | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
BioAtla
BCAB
$26.7M
| $74.1M | 11.54% | 2,515,424 -278,809 | -10% | -$8.21M |
|
2
C4 Therapeutics
CCCC
$185M
| $33.5M | 5.23% | 750,633 -120,125 | -14% | -$5.37M |
|
3
Lantheus
LNTH
$3.73B
| $31.6M | 4.92% | 1,229,827 +316,130 | +35% | +$8.12M |
|
|
DICE
4
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $28.8M | 4.49% | +879,903 | New | +$28.8M |
|
|
THER
5
DELISTED
THERATECHNOLOGIES INC COM
THER
| $28.5M | 4.45% | 7,612,383 +584,287 | +8% | +$2.19M |
|
6
Neuropace
NPCE
$303M
| $26.5M | 4.13% | 1,670,136 +285,749 | +21% | +$4.53M |
|
7
ESSA Pharma
EPIX
$11.4M
| $22.9M | 3.58% | 2,868,023 +629,919 | +28% | +$5.04M |
|
8
Surmodics
SRDX
$487M
| $21.2M | 3.31% | 381,522 +103,118 | +37% | +$5.73M |
|
9
AstraZeneca
AZN
$248B
| $19.2M | 2.99% | 319,396 +69,250 | +28% | +$4.16M |
|
|
EDAP
10
EDAP TMS
EDAP
$84.5M
| $18.9M | 2.94% | 2,956,367 +379,966 | +15% | +$2.42M |
|
|
11
United Therapeutics
UTHR
$13.8B
| $18.8M | 2.93% | +101,800 | New | +$18.8M |
|
|
ISEE
12
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $17.8M | 2.77% | 1,093,020 -1,715,323 | -61% | -$27.9M |
|
13
Natera
NTRA
$23.1B
| $15.5M | 2.41% | 138,989 +37,150 | +36% | +$4.14M |
|
14
iRadimed
IRMD
$921M
| $15.1M | 2.36% | 450,679 -46,500 | -9% | -$1.56M |
|
|
SIEN
15
DELISTED
Sientra, Inc.
SIEN
| $13.7M | 2.13% | 2,386,063 +924,500 | +63% | +$5.3M |
|
|
FLXN
16
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $12.7M | 1.98% | +2,084,050 | New | +$12.7M |
|
|
17
Enanta Pharmaceuticals
ENTA
$180M
| $10.4M | 1.61% | +182,400 | New | +$10.4M |
|
18
CRISPR Therapeutics
CRSP
$4.71B
| $10.3M | 1.61% | 92,214 -10,900 | -11% | -$1.22M |
|
19
CVRx
CVRX
$205M
| $10.2M | 1.6% | 619,065 +192,671 | +45% | +$3.19M |
|
20
Werewolf Therapeutics
HOWL
$59.9M
| $9.67M | 1.51% | 563,396 | – | – |
|
21
NeoGenomics
NEO
$1.13B
| $9.19M | 1.43% | 190,556 -161,451 | -46% | -$7.79M |
|
|
22
Organogenesis Holdings
ORGO
$653M
| $9.11M | 1.42% | +639,887 | New | +$9.11M |
|
23
Vaxcyte
PCVX
$4B
| $9.02M | 1.41% | 355,650 -20,000 | -5% | -$507K |
|
24
CareDx
CDNA
$727M
| $8.03M | 1.25% | 126,661 +97,361 | +332% | +$6.17M |
|
25
Nurix Therapeutics
NRIX
$714M
| $7.91M | 1.23% | +263,900 | New | +$7.91M |
|